Like Putnam Associates

closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/7/2018 via BNC Analysis

Ancor Capital Partners, acquired STATinMed

synopsis: Ancor Capital Partners, a Dallas-based private equity firm, announces the acquisition of STATinMED Research, a leading medical technology company in the health economics and outcomes research industry. STATinMED provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies.
buyer: Ancor Capital Partners
Ancor Capital Partners is an operations-oriented private equity firm focused on lower middle-market companies with EBITDA of $5-$15 million. Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies. "
target: STATinMed
STATinMED Research provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies. All STATinMED Research consultants hold academic positions with prestigious universities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/19/2013 via BusinessWire

Huron Consulting Group Inc., will acquire The Frankel Group Associates LLC

synopsis: Huron Consulting Group, a leading provider of business consulting services, announced that it has entered into an agreement to acquire the assets of The Frankel Group Associates LLC, a life sciences consulting firm. The acquisition will expand Huron’s strategy, advanced analytics, and regulatory compliance offerings to life sciences clients.
buyer: Huron Consulting Group Inc. (HURN:$726.27)
Huron Consulting Group helps clients in diverse industries improve performance, comply with complex regulations, reduce costs, recover from distress, leverage technology, and stimulate growth. The Company teams with its clients to deliver sustainable and measurable results. "
target: The Frankel Group Associates LLC
Frankel Group is a leading strategy consulting firm with offices in New York City, Cambridge, Massachusetts, and Tel Aviv, Israel that has served the life science industry and related segments since 1993.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2012 via BusinessWire

IMS Health Incorporated, acquired TTC LLC

synopsis: IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials. TTC offers clients a robust set of clinical trial cost benchmarks, budgeting and negotiation tools.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: TTC LLC
TTC is the leader in global clinical trial cost benchmarking. With offices in Philadelphia, TTC has a proven track record in all aspects of outsourcing cost management, from the budgeting of protocols and clinical trials to negotiations with clinical sites and other providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/21/2018 via BusinessWire

GHO Capital, acquired Validant

synopsis: GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant. Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
buyer: GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. They apply global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value."
target: Validant
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2016 via BNC Analysis

Perigord Life Science Artwork Solutions, acquired Pharma International, Inc.

synopsis: Perigord announced it has acquired Pharma International, Inc (PII). PII specializes in design, translation, medical illustration, and content development for life science company labeling and web initiatives.
buyer: Perigord Life Science Artwork Solutions
Perigord Life Science Artwork Solutions is the global leader in the provision of high quality artwork and labelling outsource services and management solutions to the Life Science industries. "
target: Pharma International, Inc.
Pharma International, Inc. (PII) specializes in design, translation, medical illustration, and content development for life science company labeling and web initiatives. PII develops labeling-related materials including Instructions for Use, Starter Kits, and patient and provider education tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/3/2015 via PR Newswire

Publicis Touchpoint Solutions, Inc., acquired Tardis Medical Consultancy

synopsis: Publicis Healthcare (PHCG) announced that it has acquired Tardis Medical, a highly respected clinical and medical affairs outsourcing organization and consultancy business. The agency will be aligned with Publicis Touchpoint Solutions, part of PHCG, Inc—a leading provider of customized, omnichannel healthcare sales, service, and clinical teams.
buyer parent: Publicis Groupe SA
buyer: Publicis Touchpoint Solutions, Inc.
Publicis Touchpoint Solutions designs and implements customized healthcare sales, service, and communications teams. They provide field sales and service, live video detailing, inside credentialed sales specialists, inside sales and service, clinical health educators, and medical science liaisons. "
target: Tardis Medical Consultancy
Tardis Medical is a Clinical and Medical Affairs consultancy, enabling pharmaceutical and life sciences companies to work as effectively as possible through: consultancy on strategic issues and operational matters, capabilities development, and resource augmentation of field based consultants.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Company Press Release

The Access Group, acquired Alliance Life Sciences

synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Alliance Life Sciences. Alliance specializes in maximizing revenue and optimizing pricing for its customers. The firm offers global pricing analytic tools and data, outsourced contract and revenue management services and digital marketing operational services.
buyer parent: Water Street Healthcare Partners
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
target: Alliance Life Sciences
Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. Its worldwide team of experts provides insights and solves problems in contracting, pricing, reimbursement, and commercial operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2005 via PR Newswire

FTI Consulting, Inc., acquired Cambio Health Solutions, LLC

synopsis: FTI Consulting, Inc., the premier provider of corporate finance/restructuring, forensic/litigation/technology and economic consulting, today announced that it has completed its previously announced acquisition of the assets of privately-held Cambio Health Solutions, LLC.
buyer: FTI Consulting, Inc. (FCN:$2,406.04)
FTI Consulting, Inc. is a global business advisory firm dedicated to helping organizations protect and enhance enterprise value in an increasingly complex legal, regulatory and economic environment. "
target: Cambio Health Solutions, LLC
FTI Healthcare is a leading provider of change management, financial advisory and specialized consulting services to healthcare providers and other healthcare businesses.
price ($mm)
$43
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/27/2013 via Company Press Release

Cumberland, purchased Life Sciences Consulting Division from Mindlance

synopsis: Cumberland Consulting Group LLC, has purchased the Mindlance Life Sciences Consulting division of Mindlance Inc., a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
buyer parent: Tailwind Capital Partners
buyer: Cumberland
Cumberland Consulting provides healthcare IT consulting services, including, Planning & Assessment; Workflow Management; Vendor Selection; Software Implementation; and Project Management to healthcare organizations. "
seller: Mindlance
Mindlance Inc., is a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2017 via PR Newswire

IntegriChain, Inc., acquired PharmaMetrics, Inc.

synopsis: IntegriChain, a rapidly growing healthcare technology company, announced the acquisition of PharmaMetrics, a leading provider of contract operations outsourcing and market access analytics software and services.
buyer parent: Accel-KKR
buyer: IntegriChain, Inc.
IntegriChain is a rapidly growing cloud software company focused on channel management for life sciences suppliers. Health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. "
target: PharmaMetrics, Inc.
PharmaMetrics is a leading provider of contract operations business process outsourcing and market access analytics, software, and services. PharmaMetrics delivers contract operations services including Medicaid processing, commercial processing, Medicare Part D, chargebacks, and government pricing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/11/2019 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired DT Associates

synopsis: Indegene, a global next-generation solutions company in the Life Sciences industry, has acquired London-based DT Associates, a consulting company focused on helping pharmaceutical companies achieve excellence in Customer Experience and Digital Operations. DT Associates will operate as a separate entity in Indegene Private Ltd, as DT Consulting.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global health care companies to address complex challenges and drive better health and business outcomes by integrating analytics, technology, operations, and medical expertise. Indegene drives innovation by combining medical expertise with contemporary digital and AI technologies. "
target: DT Associates
London-based DT Associates helps pharmaceutical firms achieve digital excellence to create successful customer experiences. DT uses fact-based insights from curated research, assessments, benchmarks, consulting projects, and more to address digital transformation in the pharmaceutical industry.
price ($mm)
$12
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/30/2016 via BNC Analysis

Wilmington plc, will acquire Evantage Consulting Ltd

synopsis: Wilmington PLC has struck a deal worth to acquire healthcare and pharmaceutical analytics firm Evantage Consulting Ltd. Evantage is the North American training partner for Axure, and helps clients around the country master Axure RP, an industry-leading rapid prototyping tool for communicating and testing UI designs.
buyer: Wilmington plc (LSE:WIL:$162.62)
Wilmington plc is a dynamic and expanding group of companies providing information and training to professional business markets. Its businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and knowledge. "
target: Evantage Consulting Ltd
Evantage Consulting Ltd. is a healthcare and pharmaceutical analytics firm. Evantage is the North American training partner for Axure, and helps clients around the country master Axure RP, an industry-leading rapid prototyping tool for communicating and testing UI designs.
price ($mm)
$1.98
rev ($mm)
$2
EBITDA ($mm)
EV / rev
5.5x
EV / EBITDA
closed 1/2/2013 via Company Press Release

Press Ganey Associates, Inc., acquired Morehead Associates

synopsis: Press Ganey Associates, Inc., a recognized leader in health care performance improvement, announced that it acquired Morehead Associates, Inc., one of the industry’s foremost employee and physician engagement firms. The acquisition strengthens Press Ganey’s comprehensive suite of patient experience solutions and services.
buyer parent: Vestar Capital Partners
buyer: Press Ganey Associates, Inc. (PGND:$344.32)
Recognized as a leader in performance improvement, Press Ganey partners with more than 10,000 health care organizations worldwide to create and sustain high performing organizations, and, ultimately, improve the overall health care experience. "
target: Morehead Associates
Morehead Associates helps leaders make better decisions and drive performance. They partner with healthcare organizations to create an engaged workforce, prioritize systemic changes, and align employees and physicians with business strategies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2011 via BNC Analysis

Southwind Health Partners, LLC, acquired PivotHealth, LLC

synopsis: The Advisory Board Company and its Southwind division announced the acquisition of substantially all the assets of PivotHealth, LLC, a physician practice management and services company serving hospitals, health systems, and large independent multi-specialty physician group practices and networks.
buyer parent: The Advisory Board Company
buyer: Southwind Health Partners, LLC
Southwind Health Partners is a physician management and consulting practice that provides physician alignment services including interim practice management, clinical integration, medical staff planning and physician practice operations improvement consulting. "
target: PivotHealth, LLC
PivotHealth is a physician practice management and services company serving hospitals, health systems, and large independent multi-specialty physician group practices and networks. PivotHealth manages medium-to-large, multi-specialty medical groups throughout the United States.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/26/2019 via Company Press Release

UDG Healthcare plc, acquired Canale Communications

synopsis: UDG Healthcare, an Ireland-based global leader in healthcare advisory, communications, commercial, clinical and packaging services, has acquired Canale Communications, a strategic communications and creative firm exclusively serving the life science and healthcare industries.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
Headquartered in Ireland, UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Canale Communications
Canale Communications is a strategic communications and creative firm exclusively serving the life science and healthcare industries. It has worked with more than 300 biotech, health tech, and pharmaceutical companies at virtually every stage of development.
price ($mm)
$20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/4/2018 via Company Press Release

Ashfield Commercial & Medical Services, acquired Create NYC

synopsis: UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of Create NYC, a New York-based disruptive creative communications agency. The business will become part of UDG's Ashfield Communications, a global leader in commercialisation services for the pharmaceutical and healthcare industry.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry. They provide field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services. "
target: Create NYC
Create NYC is an innovative New York-based healthcare creative communications agency, offering the tactical execution of sales and marketing materials for its international pharmaceutical clients.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/4/2018 via Company Press Release

Ashfield Commercial & Medical Services, acquired SmartAnalyst, Inc.

synopsis: UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of SmartAnalyst, a New York-based strategic commercialisation consulting and analytics business. The business will become part of Ashfield Communications.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry. They provide field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services. "
target: SmartAnalyst, Inc.
SmartAnalyst is a US-based strategic consulting and analytics business focused on the pharmaceutical and biotech sector. SmartAnalyst provides strategic consulting services to pharmaceutical and biotech companies to support disease, asset, and portfolio level decisions.
price ($mm)[EV]
$18 [$12]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/20/2017 via BNC Analysis

UDG Healthcare plc, acquired MicroMass Communications, Inc.

synopsis: UDG Healthcare, an international healthcare services provider, announced the acquisition of MicroMass Communications, a U.S.-based healthcare communications agency specializing in behavioural change.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare plc is a leading international partner of choice delivering clinical, commercial, communication and packaging services to the healthcare industry, employing 8,000 with operations in 23 countries and delivering services in over 50 countries. "
target parent: Periscope Equity
target: MicroMass Communications, Inc.
MicroMass Communications is a healthcare marketing agency specializing in digital, relationship marketing, and non-personal promotion. Their unique expertise in human health behavior allows them to create highly effective solutions for patients and health care providers.
price ($mm)
$64
rev ($mm)
$23
EBITDA ($mm)
EV / rev
3.3x
EV / EBITDA
closed 5/19/2016 via Company Press Release

Ashfield Commercial & Medical Services, acquired Pegasus Public Relations Ltd

synopsis: Pegasus, one of the most successful integrated healthcare communications consultancies in the UK, announced it has been acquired by UDG Healthcare plc, an international provider of outsourced healthcare services. Pegasus joins Ashfield Healthcare Communications, which is part of UDG Healthcare’s Ashfield Commercial and Medical Services Division.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in providing outsourced healthcare services to pharmaceutical, device and biotech companies. Ashfield provides contract sales teams, customer service reps, remote detailing, nurse educators, medical information, healthcare communications, and other services. "
target: Pegasus Public Relations Ltd
Pegasus specialises in helping private and public sector organisations communicate healthy messages through integrated communications programmes. Pegasus has an award-winning track record of creating and implementing campaigns that inspire behavior change.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/27/2014 via BNC Analysis

UDG Healthcare plc, acquired KnowledgePoint360

synopsis: UDG Healthcare plc, a leading international provider of healthcare services, announced that it has agreed to acquire the healthcare communications business of KnowledgePoint360. The deal, agreed at a total cash consideration of $144 million. KnowledgPoint360 provides a broad range of medical communications services.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare plc, together with its subsidiaries provides supply chain, packaging, medical, regulatory, and sales and marketing services to healthcare manufacturers and pharmacies operating in the Republic of Ireland, the United Kingdom, North America, and continental Europe. "
target parent: ABRY Partners, LLC
target: KnowledgePoint360
KnowledgPoint360 provides a broad range of medical communications services, including medical education, publication support, live educational meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions.
price ($mm)
$144
rev ($mm)
$106
EBITDA ($mm)
$20
EV / rev
1.4x
EV / EBITDA
7.2x
announced 8/28/2012 via BNC Analysis

United Drug plc, will acquire Drug Safety Alliance, Inc.

synopsis: Irish healthcare services provider United Drug plc announced an agreement to acquire North Carolina based Drug Safety Alliance Inc. DSA is a global leader in safety and risk management services supporting pharmaceutical, biotech, medical device, consumer health and animal health organizations.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Drug Safety Alliance, Inc.
Drug Safety Alliance, Inc. is a provider of clinical trial and post-marketing drug safety and pharmacovigilance solutions to the pharmaceutical and biotech industries. DSA manages services including case management, regulatory consulting, quality management, and a secure, validated safety database.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/28/2012 via BNC Analysis

United Drug plc, will acquire Synopia RX, LLC

synopsis: Irish healthcare services provider United Drug plc, announced an agreement to acquire Synopia RX LLC. SynopiaRx consults with BioTech and Pharmaceutical companies as well as investment organizations to deliver market intelligence, strategies and account management.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Synopia RX, LLC
SynopiaRx engages with companies in the BioTech and Pharmaceutical industry to optimize their commercialization of medicines in the managed care marketplace.
price ($mm)
$3.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2012 via BNC Analysis

United Drug plc, acquired Watermeadow

synopsis: United Drug plc (UD) announced that it has acquired the entire issued share capital of Watermeadow Medical Ltd and Watermeadow Medical Consulting Inc for a total consideration of up to £13m. Watermeadow is a healthcare communications and consultancy agency headquartered in the UK with offices also in the US.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Watermeadow
Watermeadow is a healthcare communications and consultancy agency headquartered in the UK with offices also in the US. It provides services to global pharmaceutical companies, including medical writing and preparation of promotional and educational materials typically for products pre-launch.
price ($mm)
$9.35
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2010 via Company Press Release

United Drug plc, acquired World Events Group, Ltd.

synopsis: United Drug, plc has acquired WorldEvents® Group, the global group of event management companies headed by WorldEvents® Group Limited. WorldEvents® is one of the UK’s top five event management businesses, specialising in the healthcare/pharmaceutical sector.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: World Events Group, Ltd.
WorldEvents® is an international event agency. WorldEvents® is ranked in the top ten event management agencies in Europe and has won numerous industry awards for the work it has conducted for its clients.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 7/29/2015 via PE Hub

Tailwind Capital Partners, acquired National HME

synopsis: Tailwind Capital, a leading middle market private equity firm investing in growth-oriented companies in healthcare, business and communications services, announced the acquisition of National HME, Inc. (“NHME”). NHME is the largest provider of outsourced medical equipment management solutions to the hospice market.
buyer: Tailwind Capital Partners
Tailwind Capital Partners is an independent private equity firm focused on investments in healthcare, media/communications and business services companies. "
target: National HME
National HME, Inc. ("NHME") is the largest provider of outsourced medical equipment management solutions to the hospice market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/2/2004 via BusinessWire

McKesson Corporation, acquired Moore Medical Corporation

synopsis: McKesson Corporation (NYSE:MCK), the world's leading healthcare services company and the largest distributor of medical surgical supplies and pharmaceuticals to the alternate site marketplace, today announced that it has completed the acquisition of Moore Medical Corporation (AMEX:MMD) of New Britain, Conn.
buyer: McKesson Corporation (MCK:$214,319.00)
McKesson Corporation, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. "
target: Moore Medical Corporation
Moore Medical Corp. is an Internet-enabled multi-channel marketer and distributor of medical, surgical and pharmaceutical products to over 100,000 healthcare practices and facilities in non-hospital settings nationwide, including physicians, emergency medical technicians, schools, correctional inst
price ($mm)
$43
rev ($mm)
$143
EBITDA ($mm)
$2
EV / rev
0.3x
EV / EBITDA
20.2x
closed 1/20/2016 via BusinessWire

ASP Global, acquired InHome Medical Solutions

synopsis: ASP Global, an industry leader in global sourcing of hospital medical supplies, has acquired Jacksonville, FL based InHome Medical Solutions, a leading wholesale medical products distribution company serving physicians, home health and hospice providers. InHome's technology platform enables clinicians to easily order and track supplies online.
buyer: ASP Global
ASP Global is a leading global sourcing agent/wholesaler of medical supplies with a proven track record. Their long-standing relationships with 120+ factories enable them to deliver high quality products at factory pricing directly to their clients. "
target: InHome Medical Solutions
InHome Medical Solutions is a leading wholesale medical products distribution company serving physicians, home health and hospice providers. InHome delivers a comprehensive range of diabetic, respiratory, urological, incontinence, wound care, ostomy, and home medical equipment products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2019 via PR Newswire

PNC Riverarch Capital, acquired Safco Dental Supply

synopsis: PNC Riverarch Capital, a middle-market private equity firm which invests in privately held companies, has acquired Safco Dental Supply, an online distributor of dental supplies to independent dental practitioners.
buyer parent: The PNC Financial Services Group
buyer: PNC Riverarch Capital
PNC Riverarch Capital is a middle-market private equity firm that invests in companies headquartered throughout North America. They work closely with their portfolio company teams to maximize their growth potential while preserving their culture and legacy. "
target: Safco Dental Supply
Safco Dental Supply is an online distributor of dental supplies to independent dental practitioners. They are known for offering top quality products at prices significantly lower than other dental supply dealers.
price ($mm)
$175
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Putnam Associates


read more

Putnam Associates

STATinMed

The Frankel Group Associates LLC

Abacus International

TTC LLC

Validant

Pharma International, Inc.

Tardis Medical Consultancy

Alliance Life Sciences

PharmARC Analytic Solutions Pvt. Ltd.

Cambio Health Solutions, LLC

Mindlance

PharmaMetrics, Inc.

DT Associates

Tri Stat

Evantage Consulting Ltd

Morehead Associates

PivotHealth, LLC

read more

Putnam Associates

read more

Canale Communications

Putnam Associates

Create NYC

SmartAnalyst, Inc.

MicroMass Communications, Inc.

Pegasus Public Relations Ltd

KnowledgePoint360

Drug Safety Alliance, Inc.

Synopia RX, LLC

Watermeadow

World Events Group, Ltd.

InforMed Direct

read more

National HME

Moore Medical Corporation

InHome Medical Solutions

Safco Dental Supply

TGaS Advisors, LLC

Geography
Matching Companies
Ticker: MCK
 
 
 
 
 
 
 
 
McKesson Corporation
McKesson Corporation
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care.
year
2019
rev ($mm)
$214,319.00
EBITDA ($mm)
$4,229.00
EBIT ($mm)
$3,280.00
Net Income ($mm)
$34.00
Employees
70000
  • drill down
  • watch
Ticker: HSIC
 
 
 
 
 
 
 
 
Henry Schein, Inc.
Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.
year
2019
rev ($mm)
$13,288.81
EBITDA ($mm)
$1,117.53
EBIT ($mm)
$905.38
Net Income ($mm)
$505.45
Employees
19000
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PDCO
 
 
 
 
 
 
 
 
Patterson Companies, Inc.
Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets. As Patterson's largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software.
year
2012
rev ($mm)
$3,535.66
EBITDA ($mm)
$400.22
EBIT ($mm)
$358.01
Net Income ($mm)
$212.82
Employees
7059
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch